GB1495026A - Canine tracheobronchitis vaccine - Google Patents

Canine tracheobronchitis vaccine

Info

Publication number
GB1495026A
GB1495026A GB4031/75A GB403175A GB1495026A GB 1495026 A GB1495026 A GB 1495026A GB 4031/75 A GB4031/75 A GB 4031/75A GB 403175 A GB403175 A GB 403175A GB 1495026 A GB1495026 A GB 1495026A
Authority
GB
United Kingdom
Prior art keywords
vaccine
tracheobrochitis
cannine
cell culture
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4031/75A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Publication of GB1495026A publication Critical patent/GB1495026A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18711Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18734Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB4031/75A 1974-02-06 1975-01-30 Canine tracheobronchitis vaccine Expired GB1495026A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44001574A 1974-02-06 1974-02-06

Publications (1)

Publication Number Publication Date
GB1495026A true GB1495026A (en) 1977-12-14

Family

ID=23747082

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4031/75A Expired GB1495026A (en) 1974-02-06 1975-01-30 Canine tracheobronchitis vaccine

Country Status (10)

Country Link
JP (1) JPS50140625A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU497239B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1039652A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2505066A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2259617B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1495026A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1030101B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7501358A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO750364L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE7501244L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Also Published As

Publication number Publication date
AU497239B2 (en) 1978-12-07
SE7501244L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-08-07
FR2259617A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-08-29
DE2505066A1 (de) 1975-08-07
NL7501358A (nl) 1975-08-08
CA1039652A (en) 1978-10-03
NO750364L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-09-01
IT1030101B (it) 1979-03-30
JPS50140625A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-11-11
FR2259617B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-08-04
AU7786875A (en) 1976-08-05

Similar Documents

Publication Publication Date Title
GB2079786B (en) Production of viral antigens
GB1495026A (en) Canine tracheobronchitis vaccine
GB1488800A (en) Influenza vaccines
GB1529576A (en) Derivatives of diphtheria toxin process for preparing them and agents containing them
GB1143996A (en) Antiviral vaccine
GB1165309A (en) Process for the preparation of Higher Aliphatic Alcohols
GB1358321A (en) Method od tissue cell culture
GB1364193A (en) 16-alkyl-17 20 21-trihydroxy-pregna 4 9/11/-dien-3-ones and deri vatives thereof
GB1436323A (en) Cell and virus culture systems
USD177777S (en) Convertible land and water craft
JPS54107511A (en) Preparation of bio-active substance
GB1211746A (en) Process for the preparation of imino-thiazolidines
GB1269659A (en) Improvements in or relating to prostaglandins and the manufacture thereof
GB1501556A (en) Cell strain and virus culture
AU209910B2 (en) Improvements in or relating to fastener driving tool
AU218302B2 (en) Improvements relating to envelopes or bags
CA613431A (en) Mass transfer from solid to gaseous stage by means of sonic energy
AU200883B2 (en) Improvements in or relating to method for concentrating and separating finely divided solids from aqueous suspension
AU200682B2 (en) Improvements in or relating to method for concentrating and separating finely divided solids from aqueous suspension
AU2242456A (en) Improvements in or relating to method of beneficiating lithium-bearing materials
AU213378B2 (en) An improved holding and guide member for steel bolts to be driven into walls by means of a powder force
CA527342A (en) Concentration of phosphate ores
CA527744A (en) Concentration of phosphate ores
AU211089B2 (en) Improvements in or relating tothe recovery of uranium values from rock phosphate
AU211213B2 (en) Improvements in or relating to windows for transferring high frequency energy

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee